Catalog

Raf

Inhibitors

Cat.No.	Name	Information
M10475	Lifirafenib (BGB-283)	Lifirafenib (BGB-283) is a novel potent and selective RAF Kinase and EGFR inhibitor with IC50 values of 23, 29 and 495 nM for the recombinant BRAFV600E kinase domain, EGFR and EGFR T790M/L858R mutant.
M10438	BI 882370	BI 882370 is a highly potent and selective RAF inhibitor that binds to the DFG-out (inactive) conformation of the BRAF kinase.
M10152	Naporafenib	Naporafenib (also known as LXH254) is an orally available inhibitor of C-Raf and B-Raf with potential antineoplastic activity.
M9492	B-Raf inhibitor 1	B-Raf inhibitor 1 is a potent and selective B-Raf inhibitor with cell IC50s of 0.31 µM and 2 nM for A375 proliferation and A375 p-ERK, respectively.
M9008	PLX7904	PLX7904, also known as PB04, is a potent and selective paradox-breaker RAF inhibitor.
M9007	PLX8394	PLX8394 is an orally bioavailable, potent and selective Raf inhibitor with IC50 of 5 nM.
M8897	B-Raf-IN-1	B-Raf-IN-1 (MDK36057) is a potent b-Raf inhibitor with IC50 of 24 nM.
M8886	RAF709	RAF709 is a novel Raf kinase inhibitor with IC50 values of 0.4 and 1.5 nM for c-Raf and b-Raf, respectively.
M5327	L-779450	L-779450 is a potent, ATP-competitive Raf kinase inhibitor (IC50 =10 nM) that displays > 7, > 30 and > 70-fold selectivity over p38α, GSK3β and Lck respectively.
M3026	Sorafenib	Sorafenib is a multikinase inhibitor of Raf-1, B-Raf and VEGFR-2 with IC50 of 6 nM, 22 nM and 90 nM, respectively.
M2927	PF-04880594	PF-04880594 is a RAF inhibitor for BRAF/BRAFV599E and c-RAF with IC50 of 0.19 nM/0.13 nM and 0.39 nM, >100-fold selectivity over CSNK1, JNK2/3 and p38.
M2813	LGX818	LGX818 is a highly potent RAF inhibitor with selective anti-proliferative and apoptotic activity in cells expressing B-RAF(V600E) with EC50 of 4 nM.
M2745	GW5074	GW5074 is a potent and selective c-Raf inhibitor with IC50 of 9 nM, no effect on the activities of JNK1/2/3, MEK1, MKK6/7, CDK1/2, c-Src, p38 MAP, VEGFR2 or c-Fms is noted.
M2319	AZ628	AZ628 is a potent inhibitor for wild-type CRAF and BRAF V600E with IC50 of 29 nM and 34 nM, respectively.
M2235	TAK-632	TAK-632 is a potent and selective pan-RAF inhibitor.
M2090	MLN2480	MLN2480 (BIIB-024) is an oral, selective pan-Raf kinase inhibitor.
M2045	CEP-32496	CEP-32496 is a potent orally active BRAF inhibitor with IC50 of 14 nM.
M1988	Dabrafenib	Dabrafenib (free base) (GSK2118436A) is a V600 mutant BRAF-specific inhibitor.
M1863	RAF265	RAF265 is a novel, orally bioavailable dual inhibitor of RAF kinase and VEGFR2.
M1855	Dabrafenib Mesylate	Dabrafenib (GSK2118436) is a selective, orally bioavailable inhibitor of Mutant B-raf (BRAF) protein kinase with potential antineoplastic activity.
M1818	ZM 336372	ZM 336372 is a potent, selective ATP-competitive inhibitor of c-Raf in vitro (IC50 = 70 nM for inhibition of human c-Raf).
M1783	SB590885	SB590885 is a selective small-molecule inhibitor of the B-Raf kinase and Ki values are 0.16 and 1.72 nM for B-Raf and c-Raf respectively.
M1774	PLX-4720	PLX-4720 is a selective BRAFV600E inhibitor with the IC50 values of 160 nM and 130 nM for B-Raf and BRK respectively.
M1761	PLX4032	PLX4032 (Vemurafenib, RG7204, RO5185426 and Zelboraf) is a highly selective B-Raf enzyme inhibitor with an IC50 of 44 nM against V600E-mutant BRAF.
M1714	GDC-0879	GDC-0879 is a potent and selective B-Raf kinase inhibitor with an EC50 of 0.75 µM.

Signaling Pathways

Product Type

Raf

Get to Know Us

Customer Support

Resources

Contact Us